Amicus Therapeutics FOLD Q4 2025 Earnings EPS Falls Far Short of Estimates Amid Thin Operational Detail TWO Q1 2026 Earnings Strong EPS Beat Masks Investor Caution NHI Q1 2026 Earnings EPS Misses Estimates Amid Stable Operations SYY Q1 2026 Earnings EPS Miss Slightly as Cost Pressures Weigh DoorDash Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher NXPI Q1 2026 Earnings EPS Beat Drives Stock Jump